June
2009
Urgent: Hydroxycut Lawsuits Have Recently Been Filed
On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products coming from a number of reports that people using the products were developing significant liver problems and other health issues. Less than a week later, on May four, the 1st Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Lawyer alleges company failure in informing the public about potential risks of the products. Naturally, it’s too soon to grasp the suit is going to turn out, but if the company had information which it didn’t divulge to customers, it should definitely be held accountable.
A class action court action is filed by a bunch of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and far less pricey, than filing an individual suit. As a rule, filing a class action court action will not cost anything unless there is a settlement. At that point, the attorney who handled the suit will take his fees from the compensation that was awarded and then distribute the leftover funds to the litigants in the case. Since this is the case, you will be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the explanations that class action lawsuits have become so popular.
The first class action legal action against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health issues due to Hydroxycut products. The FDA recall took place in the US where 23 cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage caused by the diet products, but they did receive 17 reports concerning people who sustained breathing, neurological, heart, and stomach problems as a consequence of Canadians using the products.
The Hydroxycut Settlement Suit alleges that the company sold the products without properly informing the health risks that they could exposing shoppers to. The complaint states the company failed to publish the data on the product labels saying that users could run the risk of liver and kidney damage as well as stomach, cardio, respiration, and neurological problems. The suit goes on to claim this was an obvious omission on the part of the company which deliberately misled buyers concerning the protection of the products.
